Publications (Esa Leinonen)

2020

Search PubMed

2019

  1. Pitkänen, A, Alanen, HM, Kampman, O, Suontaka-Jamalainen, K, Leinonen, E. Implementing physical exercise and music interventions for patients suffering from dementia on an acute psychogeriatric inpatient ward. Nord J Psychiatry. 2019;73 (7):401-408. doi: 10.1080/08039488.2019.1645205. PubMed PMID:31361175 .
  2. Archer, M, Kampman, O, Bloigu, A, Bloigu, R, Luoto, K, Kultti, J et al.. Assessment of alcohol consumption in depression follow-up using self-reports and blood measures including inflammatory biomarkers. Alcohol Alcohol. 2019;54 (3):243-250. doi: 10.1093/alcalc/agz002. PubMed PMID:30809628 .
  3. Archer, M, Niemelä, O, Luoto, K, Kultti, J, Hämäläinen, M, Moilanen, E et al.. Status of inflammation and alcohol use in a 6-month follow-up study of patients with major depressive disorder. Alcohol. 2019;81 :21-26. doi: 10.1016/j.alcohol.2019.02.001. PubMed PMID:30769022 .
  4. Amare, AT, Schubert, KO, Tekola-Ayele, F, Hsu, YH, Sangkuhl, K, Jenkins, G et al.. The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression. J Neural Transm (Vienna). 2019;126 (1):35-45. doi: 10.1007/s00702-018-01966-x. PubMed PMID:30610379 .

Search PubMed

2018

  1. Pitkänen, A, Alanen, HM, Kampman, O, Leinonen, E. Outcome of neuropsychiatric symptoms and daily functioning of patients with dementia treated on an acute psychogeriatric ward. Nord J Psychiatry. 2018;72 (7):521-525. doi: 10.1080/08039488.2018.1532021. PubMed PMID:30445895 .
  2. Parviainen, HM, Halava, H, Leinonen, EVJ, Kosunen, E, Rannisto, PH. Successful Curriculum Change in Health Management and Leadership Studies for the Specialist Training Programs in Medicine in Finland. Front Public Health. 2018;6 :271. doi: 10.3389/fpubh.2018.00271. PubMed PMID:30298126 PubMed Central PMC6160571.
  3. Järvenpää, S, Peltola, J, Rainesalo, S, Leinonen, E, Lehtimäki, K, Järventausta, K et al.. Reversible psychiatric adverse effects related to deep brain stimulation of the anterior thalamus in patients with refractory epilepsy. Epilepsy Behav. 2018;88 :373-379. doi: 10.1016/j.yebeh.2018.09.006. PubMed PMID:30290977 .
  4. Sorri, A, Järventausta, K, Kampman, O, Lehtimäki, K, Björkqvist, M, Tuohimaa, K et al.. Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder. Brain Behav. 2018;8 (11):e01101. doi: 10.1002/brb3.1101. PubMed PMID:30273985 PubMed Central PMC6236235.
  5. Luoto, KE, Lindholm, LH, Paavonen, V, Koivukangas, A, Lassila, A, Leinonen, E et al.. Behavioral activation versus treatment as usual in naturalistic sample of psychiatric patients with depressive symptoms: a benchmark controlled trial. BMC Psychiatry. 2018;18 (1):238. doi: 10.1186/s12888-018-1820-x. PubMed PMID:30049272 PubMed Central PMC6063001.
  6. Paavonen, V, Luoto, K, Lassila, A, Leinonen, E, Kampman, O. Temperament clusters associate with anxiety disorder comorbidity in depression. J Affect Disord. 2018;236 :252-258. doi: 10.1016/j.jad.2018.04.084. PubMed PMID:29751240 .
  7. Paavonen, V, Luoto, K, Lassila, A, Leinonen, E, Kampman, O. Temperament and character profiles are associated with depression outcome in psychiatric secondary care patients with harmful drinking. Compr Psychiatry. 2018;84 :26-31. doi: 10.1016/j.comppsych.2018.04.001. PubMed PMID:29677572 .
  8. Sorri, A, Järventausta, K, Kampman, O, Lehtimäki, K, Björkqvist, M, Tuohimaa, K et al.. Low tumor necrosis factor-α levels predict symptom reduction during electroconvulsive therapy in major depressive disorder. Brain Behav. 2018;8 (4):e00933. doi: 10.1002/brb3.933. PubMed PMID:29670819 PubMed Central PMC5893337.
  9. Archer, M, Niemelä, O, Hämäläinen, M, Moilanen, E, Leinonen, E, Kampman, O et al.. The effects of adiposity and alcohol use disorder on adipokines and biomarkers of inflammation in depressed patients. Psychiatry Res. 2018;264 :31-38. doi: 10.1016/j.psychres.2018.03.073. PubMed PMID:29626829 .
  10. Solismaa, A, Kampman, O, Lyytikäinen, LP, Seppälä, N, Viikki, M, Mononen, N et al.. Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine. J Clin Psychopharmacol. 2018;38 (3):193-199. doi: 10.1097/JCP.0000000000000885. PubMed PMID:29620694 .
  11. Amare, AT, Schubert, KO, Tekola-Ayele, F, Hsu, YH, Sangkuhl, K, Jenkins, G et al.. Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder. Front Psychiatry. 2018;9 :65. doi: 10.3389/fpsyt.2018.00065. PubMed PMID:29559929 PubMed Central PMC5845551.
  12. Andre, K, Kampman, O, Viikki, M, Setälä-Soikkeli, E, Illi, A, Mononen, N et al.. BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression. Acta Neuropsychiatr. 2018;30 (3):168-174. doi: 10.1017/neu.2017.37. PubMed PMID:29310728 .

Search PubMed